+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Primary Cells Market Size, Share & Trends Analysis Report by Origin (Human, Animal), Type (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells), Application (Regenerative Medicine), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5983054
The global primary cells market size is anticipated to reach USD 4.00 billion by 2030, growing at a CAGR of 10.39% from 2024 to 2030. The market is expected to grow due to the increased demand for monoclonal antibodies, rising cancer research, growing preference for primary human cells over cell lines, and increasing government initiatives for cell-based research.

The surge in chronic diseases globally, such as cancer and autoimmune disorders, has led to a growing demand for targeted therapies like monoclonal antibodies. The adoption of these biopharmaceuticals is on the rise as they offer an effective treatment approach by selectively targeting diseased cells while minimizing the impact on healthy ones. The production of monoclonal antibodies often involves the use of primary cells, which are cells taken directly from living organisms or tissues. Primary cells retain the genetic and phenotypic characteristics of the original tissue or organism from which they were derived, making them more authentic models for studying biological processes and producing antibodies.

Moreover, human primary cells play a crucial role in research and development in the field of cell therapy. Cell therapy involves the transplantation of cells to replace or repair damaged tissues and organs, offering promising treatment options for various diseases and conditions. Human primary cells, derived directly from living tissue, provide a more physiologically relevant model than the immortalized cell lines, making them valuable tools in cell therapy research. Donor-to-donor variability, including HLA type and CMV status, in human primary cells is important for personalized medicine approaches in cell therapy as individual differences are likely to impact treatment outcomes. Furthermore, Contract Research Organizations (CROs) specializing in primary cell derivation provide researchers access to a wide range of services related to isolating and preparing primary cells from diverse tissue sources.

Primary Cells Market Report Highlights

  • Human primary cells dominated the origin segment in 2023, owing to their importance in research as they closely resemble the physiological state of cells in vivo, thereby providing more biologically relevant data than immortalized cell lines.
  • The hematopoietic cells type segment held the largest market share in 2023. On the other hand, skeletal and muscle cells segment is expected to grow at the highest CAGR of 12.51% from 2024 to 2030.
  • In 2023, cancer research dominated the application segment and held the largest market share of 37.74%. Furthermore, the regenerative medicine segment is expected to grow at the highest CAGR over the forecast period.
  • Based on end-use, the pharmaceuticals & biotechnology companies segment held the largest market share in terms of revenue in 2023.
  • North America dominated the market for primary cells with a revenue share of 36.11% owing to the growing investments in the field of cancer research, cell therapies, and personalized and regenerative medicine.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Origin
1.2.2. Type
1.2.3. Application
1.2.4. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Primary Cells Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for monoclonal antibodies
3.2.1.2. Increasing cancer research
3.2.1.3. Increasing government initiatives for cell-based research
3.2.1.4. Growing advantages of primary human cells over cell lines
3.2.2. Market restraint analysis
3.2.2.1. Ethical and regulatory concerns related to the use of primary cells
3.3. Industry Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Primary Cells Market: Origin Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Primary Cells Market Origin Movement Analysis
4.3. Global Primary Cells Market Size & Trend Analysis, by Origin, 2018 to 2030 (USD Million)
4.4. Human Primary Cells
4.4.1. Human primary cells market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Animal Primary Cells
4.5.1. Animal primary cells market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Primary Cells Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Primary Cells Market Type Movement Analysis
5.3. Global Primary Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Hematopoietic Cells
5.4.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Skin Cells
5.5.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Hepatocytes
5.6.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Gastrointestinal Cells
5.7.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Lung Cells
5.8.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Renal Cells
5.9.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Heart Cells
5.10.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Skeletal and Muscle Cells
5.11.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Other Primary Cells
5.12.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Primary Cells Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Primary Cells Market Application Movement Analysis
6.3. Global Primary Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Drug Discovery and Development
6.4.1. Drug discovery and development market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Regenerative Medicine
6.5.1. Regenerative medicine market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cancer Research
6.6.1. Cancer research market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Primary Cells Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Primary Cells Market End-use Movement Analysis
7.3. Global Primary Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Pharmaceuticals & Biotechnology companies
7.4.1. Pharmaceuticals & Biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Academic and research institutes
7.5.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Contract research organizations
7.6.1. Contract research organizations market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Primary Cells Market: Regional Estimates & Trend Analysis By Origin, Type, Application, End-Use.
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework
8.4.4.3. Competitive scenario
8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive scenario
8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive scenario
8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Lonza
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Cell Biologics, Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. PromoCell
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. ZenBio
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. STEMCELL Technologies
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. AllCells
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. American Type Culture Collection
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Axol Biosciences Ltd.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global primary cells market, by region, 2018-2030 (USD Million)
Table 3 Global primary cells market, by origin, 2018-2030 (USD Million)
Table 4 Global primary cells market, by type, 2018-2030 (USD Million)
Table 5 Global primary cells market, by application, 2018-2030 (USD Million)
Table 6 Global primary cells market, by end-use, 2018-2030 (USD Million)
Table 7 North America primary cells market, by country, 2018-2030 (USD Million)
Table 8 North America primary cells market, by origin, 2018-2030 (USD Million)
Table 9 North America primary cells market, by type, 2018-2030 (USD Million)
Table 10 North America primary cells market, by application, 2018-2030 (USD Million)
Table 11 North America primary cells market, by end-use, 2018-2030 (USD Million)
Table 12 U.S. primary cells market, by origin, 2018-2030 (USD Million)
Table 13 U.S. primary cells market, by type, 2018-2030 (USD Million)
Table 14 U.S. primary cells market, by application, 2018-2030 (USD Million)
Table 15 U.S. primary cells market, by end-use, 2018-2030 (USD Million)
Table 16 Canada primary cells market, by origin, 2018-2030 (USD Million)
Table 17 Canada primary cells market, by type, 2018-2030 (USD Million)
Table 18 Canada primary cells market, by application, 2018-2030 (USD Million)
Table 19 Canada primary cells market, by end-use, 2018-2030 (USD Million)
Table 20 Mexico primary cells market, by origin, 2018-2030 (USD Million)
Table 21 Mexico primary cells market, by type, 2018-2030 (USD Million)
Table 22 Mexico primary cells market, by application, 2018-2030 (USD Million)
Table 23 Mexico primary cells market, by end-use, 2018-2030 (USD Million)
Table 24 Europe primary cells market, by country, 2018-2030 (USD Million)
Table 25 Europe primary cells market, by origin, 2018-2030 (USD Million)
Table 26 Europe primary cells market, by type, 2018-2030 (USD Million)
Table 27 Europe primary cells market, by application, 2018-2030 (USD Million)
Table 28 Europe primary cells market, by end-use, 2018-2030 (USD Million)
Table 29 Germany primary cells market, by origin, 2018-2030 (USD Million)
Table 30 Germany primary cells market, by type, 2018-2030 (USD Million)
Table 31 Germany primary cells market, by application, 2018-2030 (USD Million)
Table 32 Germany primary cells market, by end-use, 2018-2030 (USD Million)
Table 33 UK primary cells market, by origin, 2018-2030 (USD Million)
Table 34 UK primary cells market, by type, 2018-2030 (USD Million)
Table 35 UK primary cells market, by application, 2018-2030 (USD Million)
Table 36 UK primary cells market, by end-use, 2018-2030 (USD Million)
Table 37 France primary cells market, by origin, 2018-2030 (USD Million)
Table 38 France primary cells market, by type, 2018-2030 (USD Million)
Table 39 France primary cells market, by application, 2018-2030 (USD Million)
Table 40 France primary cells market, by end-use, 2018-2030 (USD Million)
Table 41 Italy primary cells market, by origin, 2018-2030 (USD Million)
Table 42 Italy primary cells market, by type, 2018-2030 (USD Million)
Table 43 Italy primary cells market, by application, 2018-2030 (USD Million)
Table 44 Italy primary cells market, by end-use, 2018-2030 (USD Million)
Table 45 UK primary cells market, by origin, 2018-2030 (USD Million)
Table 46 Spain primary cells market, by type, 2018-2030 (USD Million)
Table 47 Spain primary cells market, by application, 2018-2030 (USD Million)
Table 48 Spain primary cells market, by end-use, 2018-2030 (USD Million)
Table 49 Denmark primary cells market, by origin, 2018-2030 (USD Million)
Table 50 Denmark primary cells market, by type, 2018-2030 (USD Million)
Table 51 Denmark primary cells market, by application, 2018-2030 (USD Million)
Table 52 Denmark primary cells market, by end-use, 2018-2030 (USD Million)
Table 53 Sweden primary cells market, by origin, 2018-2030 (USD Million)
Table 54 Sweden primary cells market, by type, 2018-2030 (USD Million)
Table 55 Sweden primary cells market, by application, 2018-2030 (USD Million)
Table 56 Sweden primary cells market, by end-use, 2018-2030 (USD Million)
Table 57 Norway primary cells market, by origin, 2018-2030 (USD Million)
Table 58 Norway primary cells market, by type, 2018-2030 (USD Million)
Table 59 Norway primary cells market, by application, 2018-2030 (USD Million)
Table 60 Norway primary cells market, by end-use, 2018-2030 (USD Million)
Table 61 Asia Pacific primary cells market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific primary cells market, by origin, 2018-2030 (USD Million)
Table 63 Asia Pacific primary cells market, by type, 2018-2030 (USD Million)
Table 64 Asia Pacific primary cells market, by application, 2018-2030 (USD Million)
Table 65 Asia Pacific primary cells market, by end-use, 2018-2030 (USD Million)
Table 66 China primary cells market, by origin, 2018-2030 (USD Million)
Table 67 China primary cells market, by type, 2018-2030 (USD Million)
Table 68 China primary cells market, by application, 2018-2030 (USD Million)
Table 69 China primary cells market, by end-use, 2018-2030 (USD Million)
Table 70 Japan primary cells market, by origin, 2018-2030 (USD Million)
Table 71 Japan primary cells market, by type, 2018-2030 (USD Million)
Table 72 Japan primary cells market, by application, 2018-2030 (USD Million)
Table 73 Japan primary cells market, by end-use, 2018-2030 (USD Million)
Table 74 India primary cells market, by origin, 2018-2030 (USD Million)
Table 75 India primary cells market, by type, 2018-2030 (USD Million)
Table 76 India primary cells market, by application, 2018-2030 (USD Million)
Table 77 India primary cells market, by end-use, 2018-2030 (USD Million)
Table 78 South Korea primary cells market, by origin, 2018-2030 (USD Million)
Table 79 South Korea primary cells market, by type, 2018-2030 (USD Million)
Table 80 South Korea primary cells market, by application, 2018-2030 (USD Million)
Table 81 South Korea primary cells market, by end-use, 2018-2030 (USD Million)
Table 82 Australia primary cells market, by origin, 2018-2030 (USD Million)
Table 83 Australia primary cells market, by type, 2018-2030 (USD Million)
Table 84 Australia primary cells market, by application, 2018-2030 (USD Million)
Table 85 Australia primary cells market, by end-use, 2018-2030 (USD Million)
Table 86 Thailand primary cells market, by origin, 2018-2030 (USD Million)
Table 87 Thailand primary cells market, by type, 2018-2030 (USD Million)
Table 88 Thailand primary cells market, by application, 2018-2030 (USD Million)
Table 89 Thailand primary cells market, by end-use, 2018-2030 (USD Million)
Table 90 Latin America primary cells market, by country, 2018-2030 (USD Million)
Table 91 Latin America primary cells market, by origin, 2018-2030 (USD Million)
Table 92 Latin America primary cells market, by type, 2018-2030 (USD Million)
Table 93 Latin America primary cells market, by application, 2018-2030 (USD Million)
Table 94 Latin America primary cells market, by end-use, 2018-2030 (USD Million)
Table 95 Brazil primary cells market, by origin, 2018-2030 (USD Million)
Table 96 Brazil primary cells market, by type, 2018-2030 (USD Million)
Table 97 Brazil primary cells market, by application, 2018-2030 (USD Million)
Table 98 Brazil primary cells market, by end-use, 2018-2030 (USD Million)
Table 99 Argentina primary cells market, by origin, 2018-2030 (USD Million)
Table 100 Argentina primary cells market, by type, 2018-2030 (USD Million)
Table 101 Argentina primary cells market, by application, 2018-2030 (USD Million)
Table 102 Argentina primary cells market, by end-use, 2018-2030 (USD Million)
Table 103 MEA primary cells market, by country, 2018-2030 (USD Million)
Table 104 MEA primary cells market, by origin, 2018-2030 (USD Million)
Table 105 MEA primary cells market, by type, 2018-2030 (USD Million)
Table 106 MEA primary cells market, by application, 2018-2030 (USD Million)
Table 107 MEA primary cells market, by end-use, 2018-2030 (USD Million)
Table 108 South Africa primary cells market, by origin, 2018-2030 (USD Million)
Table 109 South Africa primary cells market, by type, 2018-2030 (USD Million)
Table 110 South Africa primary cells market, by application, 2018-2030 (USD Million)
Table 111 South Africa primary cells market, by end-use, 2018-2030 (USD Million)
Table 112 Saudi Arabia primary cells market, by origin, 2018-2030 (USD Million)
Table 113 Saudi Arabia primary cells market, by type, 2018-2030 (USD Million)
Table 114 Saudi Arabia primary cells market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia primary cells market, by end-use, 2018-2030 (USD Million)
Table 116 UAE primary cells market, by origin, 2018-2030 (USD Million)
Table 117 UAE primary cells market, by type, 2018-2030 (USD Million)
Table 118 UAE primary cells market, by application, 2018-2030 (USD Million)
Table 119 UAE primary cells market, by end-use, 2018-2030 (USD Million)
Table 120 Kuwait primary cells market, by origin, 2018-2030 (USD Million)
Table 121 Kuwait primary cells market, by type, 2018-2030 (USD Million)
Table 122 Kuwait primary cells market, by application, 2018-2030 (USD Million)
Table 123 Kuwait primary cells market, by end-use, 2018-2030 (USD Million)
Table 124 Participant's overview
Table 125 Financial performance
Table 126 Key companies undergoing expansions
Table 127 Key companies undergoing acquisitions
Table 128 Key companies undergoing collaborations
Table 129 Key companies launching new products/services
Table 130 Key companies undertaking other strategies
List of Figures
Figure 1 Primary cells market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Parent market outlook
Figure 13 Related/ancillary market outlook
Figure 14 Primary cells market driver analysis
Figure 15 Primary cells market restraint analysis
Figure 16 Primary cells market: Porter's analysis
Figure 17 Primary cells market: Origin outlook key takeaways
Figure 18 Primary cells market: Origin movement analysis
Figure 19 Human primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Animal primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Primary cells market: Type outlook key takeaways
Figure 22 Primary cells market: Type movement analysis
Figure 23 Hematopoietic Cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Skin cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Hepatocytes market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Gastrointestinal cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Lung cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Renal cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Heart cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Skeletal and muscle cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Other primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Primary cells market: Application outlook key takeaways
Figure 33 Primary cells market: Application movement analysis
Figure 34 Drug discovery and development market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Regenerative medicine market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Cancer research market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Primary cells market: End-use outlook key takeaways
Figure 39 Primary cells market: End-use movement analysis
Figure 40 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Academic and research institutes market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Contract research organizations market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Regional marketplace outlook, 2023 & 2030 (USD Million)
Figure 44 Regional marketplace: Key takeaways
Figure 45 North America primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Key country dynamics
Figure 47 U.S. primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 Canada primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 Mexico primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Key country dynamics
Figure 53 Europe primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key country dynamics
Figure 55 UK primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Key country dynamics
Figure 57 Germany primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Key country dynamics
Figure 59 France primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Key country dynamics
Figure 61 Spain primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 Italy primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Denmark primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 Sweden primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Norway primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 Asia Pacific primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 Japan primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 China primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 India primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 Australia primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Thailand primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Latin America primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Brazil primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 Argentina primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 MEA primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 South Africa primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Saudi Arabia primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 UAE primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Key country dynamics
Figure 99 Kuwait primary cells market estimates and forecasts, 2018-2030 (USD Million)
Figure 100 Key country dynamics
Figure 101 Market participant categorization
Figure 102 Global primary cells market position analysis, 2023
Figure 103 Strategic framework

Companies Mentioned

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell
  • ZenBio
  • STEMCELL Technologies
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd.

Methodology

Loading
LOADING...

Table Information